ELIGIX
Eligix, Inc., a biomedical company, engages in the research and development of cellular therapies. The therapies improve human immune response to cancers, autoimmune disorders, and solid organ transplants; and reduce the risk of infection and hypersensitivity reactions in blood transfusions.
ELIGIX
Industry:
Biotechnology Health Care Market Research Mobile Therapeutics
Address:
Medford, Massachusetts, United States
Country:
United States
Status:
Active
Similar Organizations
Cetek Corporation
Cetek Corporation is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics.
Incumed
Incumed, Inc., a medical device incubator, engages in the creation and development of medical products.
ISCT, International Society for Cell & Gene Therapy
ISCT is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Salus IRB
Salus IRB conducts reviews for all stages of research in a wide range of therapeutic areas and study designs.
Topigen Pharmaceuticals
TOPIGEN is a biotech company engaged in scientific research and development of novel therapeutic drugs.
More informations about "Eligix"
Eligix Company Profile 2024: Valuation, Investors, Acquisition
Eligix General Information Description. Developer of transplantation and immune therapies for cancers and infectious diseases. The company aims to develop therapies for achieving …See details»
Eligix - Products, Competitors, Financials, Employees, …
Headquarters Location. 200 Boston Avenue . Medford, Massachusetts, 02155, United States. 781-393-8500See details»
Miltenyi Biotec acquires Eligix - 2003-06-02 - Crunchbase
Jun 2, 2003 Eligix Eligix, Inc., a biomedical company, engages in the research and development of cellular therapies. Acquiring Organization: Miltenyi Biotec Design, development, …See details»
Eligix Inc - Company Profile and News - Bloomberg Markets
Company profile page for Eligix Inc including stock price, company news, executives, board members, and contact informationSee details»
Eligix, Inc Company Profile | Medford, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Eligix, Inc of Medford, MA. Get the latest business insights from Dun & Bradstreet.See details»
Eligix - Crunchbase
Eligix, Inc., a biomedical company, engages in the research and development of cellular therapies.See details»
EligiX - Company Profile - Tracxn
EligiX - Statistical reporting and decision mapping tools. Acquired by BioTransplant. Raised funding from 2 investors. EligiX has 1064 competitors.See details»
Eligix, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jun 19, 2023 Clinical Trials associated with Eligix, Inc. NCT00038818 / Terminated Not Applicable. CD8 Depleted Donor Lymphocyte Infusions for Patients With Relapse Or Residual …See details»
Organization | Eligix
Eligix Report issue. For profit. Founded: Medford MA United States ... Organization Overview. First Clinical Trial. 2001 NCT00038818. First Marketed Drug. None First NDA Approval. None ...See details»
BioTransplant to buy Eligix for $55.3 million
BioTransplant has signed an agreement to acquire Eligix, aprivately-owned biomedical device company, in a move which the former says supports its "strategic vision to become the leading …See details»
EligiX - Raised Funding from 2 investors - Tracxn
EligiX has raised funding from 2 investors. Investors include Adams Street Partners and MedVenture Associates.See details»
ELIGIX, A Canada Trademark of ELIGIX, INC.,a Delaware …
ELIGIX is a canadian trademark and brand of ELIGIX, INC.,a Delaware corporation,, Second Floor,, Medford, Massachusetts 02155,,UNITED STATES. This trademark was filed to the …See details»
Eligix Stock Price, Funding, Valuation, Revenue & Financial …
See Eligix funding rounds, investors, investments, exits and more. Evaluate their financials based on Eligix's post-money valuation and revenue. Eligix Stock Price, Funding, Valuation, Revenue …See details»
ELIGIX Trademark of Eligix, Inc.. Application Number: 001308071 ...
ELIGIX is a trademark and brand of Eligix, Inc., Medford, Massachusetts 02155, UNITED STATES. This trademark was filed to EUIPO on Tuesday, September 14, 1999. The ELIGIX is …See details»
BioTransplant Acquiring Eligix In Stock Deal Valued At $55M
Dec 12, 2000 In a strategic move to further develop its cell, tissue and organ transplantation business beyond its current level, BioTransplant Inc. said Monday it will acquire Eligix Inc., a …See details»
Eligix Management Team - CB Insights
Explore {Eligix's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Eligix CEO, Founder, Key Executive …See details»
Importance of Low Incurred Sample Reanalysis Failure Rates
Apr 22, 2019 More importantly, having a low Incurred Sample Reanalysis failure rate from your contract research organization (CRO) is important for several reasons: ... and previously …See details»
EligiX - Overview, News & Similar companies | ZoomInfo.com
EligiX optimise vos données en une carte par le biais dune analyse approfondie de vos données. Cela vous permet dobtenir un support de communication efficace et pertinent. Read More. …See details»
eLogix – Axestrack
Smart Window for Intelligent Global Freight Transportation With eLogiX, our mission is to empower major transportation fleets around the world by revolutionizing their operational …See details»